Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Anomalies of the Distal Tubule

  • - General Urology - Common Urological Problems - Medical Renal Disease
  • Jul 29, 2010
  • Comments
  • Viewed: 16039
  
Tags: | bicarbonate reabsorption | defects of water absorption | demeclocycline | distal tubule |

Defects of Hydrogen Ion Secretion & Bicarbonate Reabsorption (Classic Renal Tubular Acidosis, Type I)
Failure to secrete hydrogen ion and to form ammonium ion results in loss of “fixed base” sodium, potassium, and calcium.  There is also a high rate of excretion of phosphate. Vomiting, poor growth, and symptoms and signs of chronic metabolic acidosis are accompanied by weakness due to potassium deficit and bone discomfort due to osteomalacia. 

Nephrocalcinosis,  with calcification in the medullary portions of the kidney, occurs in about one-half of cases. The urine is alkaline and contains larger than normal quantities of sodium, potassium, calcium, and phosphate. 

An abnormality in urinary anion gap (U.Na+  + U.K+ -  U.Cl-) is noted (low), which is associated with the reduced NH4+ production. This abnormality differentiates this condition from type II RTA and from the metabolic acidosis seen with diarrhea. The blood chemistry findings are those of metabolic acidosis with low serum potassium.

Treatment consists of replacing deficits and increasing the intake of sodium, potassium, calcium, and phosphorus. Sodium and potassium should be given as bicarbonate or citrate. Additional vitamin D may be required.

Diagnosis of Medical Renal Disease

Medical Renal Disease

Excess Potassium Secretion (Potassium “Wastage” Syndrome)
Excessive renal secretion or loss of potassium may occur in 4 situations:  (1)  moderate renal insufficiency with diminished H+ secretion; (2) RTA (proximal and distal RTA);  (3)  hyperaldosteronism and hyperadrenocorticism; and (4) tubular secretion of potassium, the cause of which is unknown. Hypokalemia indicates that the deficit is severe.  Muscle weakness and polyuria and dilute urine are signs attributable to hypokalemia.  Treatment consists of correcting the primary disease and giving supplementary potassium.

Reduced Potassium Secretion
Reduced potassium secretion is noted in conditions in which extrarenal aldosterone is reduced or when intrarenal production of renin (and secondary hypoaldosteronism) occurs. The latter condition is termed RTA, type IV, and is associated with impaired H+ and K+ secretion in the distal tubule. Drug-induced interstitial nephritis, gout,  and diabetes mellitus are clinical circumstances that may produce type IV RTA and resulting hyperkalemia and mild metabolic acidosis.  Treatment is to promote kaliuresis (with loop diuretics) to prescribe potassium-binding gastrointestinal resins (Kayexalate),  or to provide the patient with a mineralocorticoid, fludrocortisone acetate.

Defects of Water Absorption (Renal Diabetes Insipidus)
Nephrogenic diabetes insipidus occurs more frequently in males than females. Unresponsiveness to antidiuretic hormone is the key to differentiation from pituitary diabetes insipidus.

In addition to congenital refractoriness to antidiuretic hormone, obstructive uropathy, lithium, methoxyflurane, and demeclocycline also may render the tubule refractory to vasopressin.

Symptoms are related to an inability to reabsorb water, with resultant polyuria and polydipsia. The urine volume approaches 12 L/d, and osmolality and specific gravity are low.

Treatment consists primarily of an adequate water intake.  Chlorothiazide may ameliorate the polyuria;  the mechanism of action is unknown, but the drug may act by increasing isosmotic reabsorption in the proximal segment of the tubule.


Unspecified Renal Tubular Abnormalities

In idiopathic hypercalciuria, decreased reabsorption of calcium predisposes to the formation of renal calculi. Serum calcium and phosphorus are normal. Urine calcium excretion is high;  urine phosphorus excretion is low.  Microscopic hematuria may be present. See treatment of urinary stones containing calcium.


***
Flavio G. Vincenti, MD, & William J.C. Amend, Jr., MD

***
REFERENCES

  1. Adler S: Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney Int 2004;66:2095.
  2. Alric L et al: Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 2004;43:617.
  3. Appel GB et al: Membranoproliferative glomerulonephritis Type II (dense deposit disease): An update. J Amer Soc Neph 2005;16: 1392.
  4. Barratt J, Feehally J: IgA nephropathy. J Amer Soc Neph 2005;16: 2088.
  5. Braden GL et al: Tubulointerstitial diseases. Am J Kidney Dis 2005; 46:560.
  6. Buhaescu I et al: Systemic vasculitis: Still a challenging disease. Am J Kidney Dis 2005;46:173.
  7. Chesney R: The changing face of childhood nephrotic syndrome. Kidney Int 2004;66:1294.
  8. Flanc RS et al: Treatment of diffuse proliferative lupus nephritis: A meta-analysis of randomized controlled trials. Am J Kidney Dis 2004;43:197.
  9. Couser WG (guest editor): Frontiers in nephrology: Membranous nephropathy. J Amer Soc Neph 2005;16:1184.
  10. Ginzler EM et al: Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005;353:2219.
  11. Grantham JJ: Advancement in the understanding of polycystic kidney disease: A system approach. Kidney Int 2003;64: 1154.
  12. Heering P et al: Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis 2004;43:10.
  13. Hruska KA: Treatment of chronic tubulointerstitial disease: A new concept. Kidney Int 2002;61:1911.
  14. Imaging the Kidney-Radiologic Imaging 2006. (Excerpts) Nephron Clin Pract 2006;103:c19.
  15. Izzedine H et al: Oculorenal manifestations in systemic autoimmune diseases. Am J Kidney Dis 2004;43:209.
  16. Javaid B, Quigg RJ: Treatment of glomerulonephritis: Will we ever have options other than steroids and cytotoxics? Kidney Int 2005;67:1692.
  17. Nair R, Walker PD: Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int 2006;69:1455.
  18. Noris M, Remuzzi G: Hemolytic uremic syndrome. J Amer Soc Neph 2005;16:1035.
  19. Perna A et al: Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic review. Am J Kidney Disease 2004;44:385.
  20. Rosner MH, Bolton WK: Renal function testing. Am J Kidney Dis 2006;47:174.
  21. Rossert J: Drug-induced acute interstitial nephritis. Kidney Int 2001; 60:804.
  22. Tenenhouse HS, Murer H: Disorders of renal tubular phosphate transport. J Am Soc Neph 2003;14:240.
  23. Troyanov S et al: Renal pathology in idiopathic membranous nephropathy: A new perspective. Kidney Int 2006;69:1641.
  24. Wilmer WA et al: Management of glomerular proteinuria: A commentary. J Amer Soc Neph 2003;14:3217.

Bookmark and Share

Post a comment [ + Comment here + ]

There are no comments for this entry yet. [ + Comment here + ]




Comment
Your details

* Required field


Please enter the word you see in the image below:

Comments are moderated by our editors, so there may be a delay between submission and publication of your comment. Offensive or abusive comments will not be published.

calcium channel1 - national cancer institute1 - urethral discharge2 - stone varieties1 - intermittent therapy1 - silicate stones1 - radical prostatectomy9 - female urethra1 - surgery and radiation therapy1 - nephrogenesis1 - sers1 - sodium2 - androgen deprivation therapy5 - irregular heart rhythm1 - radiation2 - severe lower urinary tract symptoms1 - triage1 - onset1 - psa velocity1 - pluripotent stem cells1 - itraconazole1 - zetia1 - medullary cystic disease1 - overhydration1 - urine7 - neurological disorders1 - pubocervical fascia1 - apple shape1 - munchausen syndrome1 - primary hematuria1 -